VBID is a promising approach to improving health and cost outcomes, but its use has been limited. Expanding it to complicated interventions will require a lot of effort.
Michael D. Dalzell
The National Business Group on Health’s CEO looks for employers and insurers to collaborate to improve patient safety and cut costs
Once in a while something comes up that requires the sort of immediate and intense intervention that’s downright heroic
Lax regulations and fee-for-service payment make an irresistible mix for physician conflicts. Are ACOs the answer?
Richard Mark Kirkner
Medco’s ‘gaps in care’ approach saves $900 million by targeting 15 chronic conditions
This is no one-size-fits-all solution, as insurers across the country tailor efforts for specific markets
A widely available but underused molecular genetic blood test has proved to be accurate over 98% of the time and costs less than $400
Michael Graf, MS
In a system where people will soon shop for their benefits on exchanges, plans that offer the best customer service will have the edge
Jeff Kang, MD
Health plans are expanding MTM — once considered a Part D mainstay — to their commercial businesses.
A summary of the ECRI Institute’s Emerging Technology Evidence Report
The Formulary Files
Legislation & Regulation
The need for health plans to cut administrative costs is hammering insurance brokers. Is this another instance of the law of unintended consequences?
Brilinta’s price will be a significant factor in coverage decisions when Plavix goes off patent in May 2012
Thomas Morrow, MD
If UnitedHealth Group’s effort to buy a large physician group proves successful, clinical execs will have even more oversight
Managed Care Outlook